Q32 Bio (QTTB) Non-Current Debt (2023 - 2026)

Q32 Bio's Non-Current Debt history runs 4 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Non-Current Debt fell 75.88% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 75.88% YoY), while the FY2025 annual figure was $3.5 million, down 63.66% from the prior year.
• Non-Current Debt was $1.9 million for Q1 2026 at Q32 Bio, down from $3.5 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $12.6 million in Q2 2024 to a low of $1.9 million in Q1 2026.
• Historically, Non-Current Debt has averaged $7.2 million across 4 years, with a median of $7.3 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Non-Current Debt jumped 108.6% in 2024, then tumbled 75.88% in 2026.
• A 4-year view of Non-Current Debt shows it stood at $4.6 million in 2023, then surged by 108.6% to $9.6 million in 2024, then plunged by 63.66% to $3.5 million in 2025, then tumbled by 44.17% to $1.9 million in 2026.
• The last three Non-Current Debt figures came in at $1.9 million (Q1 2026), $3.5 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.